Skip to search formSkip to main contentSkip to account menu

Polymorphic Post-Transplant Lymphoproliferative Disorder

Known as: Polymorphic B-Cell Lymphoma, Polymorphic PTLD 
A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
It is currently unclear whether post‐transplant diffuse large B‐cell lymphomas (PT‐DLBCL) display a similar genomic landscape as… 
Review
2017
Review
2017
BackgroundPost-transplant lymphoproliferative disorder is a well-recognized but rare complication of hematopoietic stem cell and… 
2016
2016
Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous group of lymphoid neoplasms occurring as a result of… 
2010
2010
Kerkar N, Morotti RA, Madan RP, Shneider B, Herold BC, Dugan C, Miloh T, Karabicak I, Strauchen JA, Emre S. The changing face of… 
Review
2009
Review
2009
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication after pediatric… 
Highly Cited
2007
Highly Cited
2007
Background. Single-agent rituximab has demonstrated encouraging efficacy and tolerability in posttransplant lymphoproliferative… 
Review
2006
Review
2006
Post-transplant lymphoproliferative disorder is the most common malignancy, with the exception of skin cancer, after solid organ… 
2006
2006
Post-transplant lymphoproliferative disease (PTLD) is a rare, but serious and potentially lethal complication of solid organ… 
Review
2004
Review
2004
Post-transplant lymphoproliferative disorders are mostly Epstein–Barr virus-related, B-cell tumors that develop as a consequence… 
2004
2004
CONTEXT Posttransplant B-cell lymphoproliferative disorders (PTLDs) constitute a heterogeneous group that includes hyperplastic…